Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) EPS (Basic) (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed EPS (Basic) for 12 consecutive years, with $0.63 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 122.18% year-over-year to $0.63, compared with a TTM value of -$3.72 through Sep 2025, up 10.58%, and an annual FY2024 reading of -$5.17, up 54.21% over the prior year.
  • EPS (Basic) was $0.63 for Q3 2025 at Arcadia Biosciences, up from -$3.26 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $6.53 in Q3 2022 and bottomed at -$17.19 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$1.87, with a median of -$0.43 recorded in 2021.
  • The sharpest move saw EPS (Basic) surged 6036.36% in 2022, then plummeted 5225.0% in 2023.
  • Year by year, EPS (Basic) stood at -$0.43 in 2021, then crashed by 3897.67% to -$17.19 in 2022, then surged by 88.48% to -$1.98 in 2023, then tumbled by 51.01% to -$2.99 in 2024, then skyrocketed by 121.07% to $0.63 in 2025.
  • Business Quant data shows EPS (Basic) for RKDA at $0.63 in Q3 2025, -$3.26 in Q2 2025, and $1.9 in Q1 2025.